
Zoetis Faces Securities Class Action Over Alleged Misleading Disclosures
Investors who purchased Zoetis Inc. stock between January 14, 2025, and May 6, 2026, are being urged to join a class action lawsuit filed against the pharmaceutical company. The litigation alleges that the firm violated federal securities laws by issuing false statements regarding the performance of its core product lines.















